Why Shepherd Kaplan Krochuk Reported Escalon Medical Corp Position?

February 14, 2018 - By Ellis Scott

 Why Shepherd Kaplan Krochuk Reported Escalon Medical Corp Position?

The New Shepherd Kaplan Krochuk Holding in Escalon Medical Corp

Shepherd Kaplan Krochuk reported SC 13G/A form with the SEC for Escalon Medical Corp. Access it here: 000091957418001153. As reported by Shepherd Kaplan Krochuk, the filler owns 4.11% or 310,171 shares of the Health Care–company.

Escalon Medical Corp stake is new for [reportingPerson]. Date of activity: December 31, 2017. This shows Shepherd Kaplan Krochuk’s positive view for Escalon Medical Corp. For a hedge fund managing $953.78 million in assets and having 20+ experts this is interesting position.

The hedge fund is investor in the Health Care sector. In the manager’s last 13-F, we saw 12% of Shepherd Kaplan Krochuk’s portfolio is in the sector.

Escalon Medical Corp Institutional Sentiment

Filings show 14 investors own Escalon Medical Corp. The ownership in Q3 2015 is low, at Infinity of the outstanding shares. This is increased by 7029174. 8198741 were owned by these investors. 2 funds opened new Escalon Medical Corp stakes, 3 increased positions. There were 4 that closed positions and 3 reduced them.

Blackrock Institutional Trust Company is an investor bullish on Escalon Medical Corp, owning 271235 shares as of Q3 2015 for less than 0.01% of its portfolio. Jim Simons Renaissance Technologies Llc owns 218800 shares or less than 0.01% of its portfolio. MA Grt Capital Partners Llc have 0.16% of its portfolio for 509164 shares. Further, Vanguard Group Inc reported stake worth 0.01% of its portfolio. The CT Yale University owns 2703700 shares. Escalon Medical Corp is 29.59% of its portfolio.

Business Profile

Escalon Medical Corp. operates in the healthcare market. The Company is engaged in the development, manufacture, marketing and distribution of medical devices and pharmaceuticals in the area of ophthalmology. Its A-Scan provides information about the internal structure of the eye by sending a beam of ultrasound along a fixed axis through the eye and displaying the various echoes reflected from the surfaces intersected by the beam. Its B-Scan is a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque. Its UBM is a high frequency/high resolution ultrasound device, designed to provide information about the anterior segment of the eye. The Company’s pachymeter measures the thickness of the cornea. Its color/fluorescein angiography digital imaging system is designed for ophthalmology. It distributes two intraocular gas products, C3F8 and SF6, which are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery.

SEC Form 13G.

Shepherd Kaplan Krochuk website.

It closed at $0.2089 lastly. It is down 0.00% since February 14, 2017 and is . It has underperformed by 16.70% the S&P500.

Escalon Medical Corp. develops, manufactures, markets, and distributes medical devices and pharmaceuticals in the area of ophthalmology in the United States, Europe, and Asia. The company has market cap of $1.58 million. It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque; UBM, a high frequency/high resolution ultrasound device, which provides detailed information about the anterior segment of the eye; and pachymeter that measures the thickness of cornea. It currently has negative earnings. The firm also provides color/fluorescein angiography digital imaging systems that are primarily used in detecting retinal problems in diabetic and elderly patients; distributes intraocular gas products, such as C3F8 and SF6, which are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery; and makes and distributes a patented disposable universal gas kit that delivers the gas from the canister to the patient.

More important recent Escalon Medical Corp. (OTCMKTS:ESMC) news were published by: Businesswire.com which released: “ERBA Diagnostics, Inc. Acquires Escalon Medical Corp. Clinical Diagnostics …” on October 04, 2012, also Prnewswire.com published article titled: “Escalon® Medical Corp. Reports Fiscal 2015 Results”, Prnewswire.com published: “Escalon® Medical Corp. to Introduce Sonomed Escalon VuPadâ„¢ at Annual Meeting …” on November 14, 2013. More interesting news about Escalon Medical Corp. (OTCMKTS:ESMC) was released by: Prnewswire.com and their article: “Sonomed Escalonâ„¢ Announces Integration of AXISâ„¢ Image Management with …” with publication date: June 24, 2013.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.